COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,451 | -48.1% | 16,575 | -50.1% | 0.00% | – |
| Q2 2023 | $713,404 | +55.9% | 33,197 | +74.1% | 0.00% | – |
| Q1 2023 | $457,466 | -11.7% | 19,069 | -14.6% | 0.00% | – |
| Q4 2022 | $518,241 | +12.9% | 22,338 | -22.0% | 0.00% | – |
| Q3 2022 | $459,000 | -5.9% | 28,651 | +4.1% | 0.00% | – |
| Q2 2022 | $488,000 | -44.7% | 27,526 | -36.5% | 0.00% | -100.0% |
| Q1 2022 | $883,000 | +21.0% | 43,381 | +11.0% | 0.00% | – |
| Q4 2021 | $730,000 | +19.1% | 39,089 | +25.9% | 0.00% | – |
| Q3 2021 | $613,000 | +3.2% | 31,049 | +23.5% | 0.00% | – |
| Q2 2021 | $594,000 | +15.6% | 25,147 | +15.8% | 0.00% | – |
| Q1 2021 | $514,000 | +129.5% | 21,722 | +94.6% | 0.00% | – |
| Q4 2020 | $224,000 | +13.1% | 11,165 | +17.8% | 0.00% | – |
| Q3 2020 | $198,000 | -74.1% | 9,475 | -78.3% | 0.00% | -100.0% |
| Q2 2020 | $764,000 | +276.4% | 43,670 | +252.0% | 0.00% | – |
| Q1 2020 | $203,000 | -49.9% | 12,408 | -36.9% | 0.00% | – |
| Q4 2019 | $405,000 | +170.0% | 19,663 | +50.4% | 0.00% | – |
| Q3 2019 | $150,000 | -82.9% | 13,075 | -80.4% | 0.00% | -100.0% |
| Q2 2019 | $877,000 | -4.0% | 66,718 | +10.5% | 0.00% | 0.0% |
| Q1 2019 | $914,000 | -66.2% | 60,362 | -61.7% | 0.00% | -66.7% |
| Q4 2018 | $2,704,000 | +232.6% | 157,508 | +185.6% | 0.00% | +200.0% |
| Q3 2018 | $813,000 | +1113.4% | 55,143 | +1865.9% | 0.00% | – |
| Q2 2018 | $67,000 | +2133.3% | 2,805 | +2108.7% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 127 | -41.2% | 0.00% | – |
| Q4 2017 | $4,000 | -81.8% | 216 | -89.6% | 0.00% | – |
| Q3 2017 | $22,000 | -21.4% | 2,070 | -7.7% | 0.00% | – |
| Q2 2017 | $28,000 | +40.0% | 2,242 | +10.1% | 0.00% | – |
| Q1 2017 | $20,000 | -13.0% | 2,036 | +35.7% | 0.00% | – |
| Q4 2016 | $23,000 | -20.7% | 1,500 | 0.0% | 0.00% | – |
| Q3 2016 | $29,000 | -57.4% | 1,500 | -73.9% | 0.00% | – |
| Q2 2016 | $68,000 | -59.3% | 5,756 | -37.5% | 0.00% | – |
| Q1 2016 | $167,000 | +25.6% | 9,208 | +90.2% | 0.00% | – |
| Q4 2015 | $133,000 | – | 4,841 | +484000.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 1 | -98.9% | 0.00% | – |
| Q2 2015 | $2,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |